The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Concurrent genetic alterations identified by next-generation sequencing in pre-treatment, metastatic EGFR-mutant lung cancers.
 
Helena Alexandra Yu
Consulting or Advisory Role - AstraZeneca
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Clovis Oncology (Inst); Esanex (Inst); Incyte (Inst); Pfizer (Inst)
 
Emmet Jordan
No Relationships to Disclose
 
Ai Ni
No Relationships to Disclose
 
Daniel Feldman
No Relationships to Disclose
 
Christopher Rodriguez
No Relationships to Disclose
 
Hyunjae Ryan Kim
No Relationships to Disclose
 
Mark G. Kris
Consulting or Advisory Role - ARIAD; Array BioPharma; AstraZeneca; Clovis Oncology; Daiichi Sankyo; Genentech/Roche; Pfizer; Threshold Pharmaceuticals
Research Funding - Pfizer (Inst); Puma Biotechnology (Inst)
 
David B. Solit
Honoraria - Loxo; Novartis; Pfizer
Consulting or Advisory Role - Loxo; Pfizer
 
Michael F. Berger
Consulting or Advisory Role - Cancer Genetics; Sequenom
 
Marc Ladanyi
Stock and Other Ownership Interests - Foundation Medicine
Consulting or Advisory Role - NCCN/Boehringer Ingelheim
 
Maria E. Arcila
Consulting or Advisory Role - AstraZeneca
Travel, Accommodations, Expenses - AstraZeneca
Other Relationship - Raindance Technologies
 
Gregory J. Riely
Honoraria - Celgene
Consulting or Advisory Role - ARIAD; Mersana; Novartis; Novartis; Roche
Research Funding - GlaxoSmithKline (Inst); Infinity Pharmaceuticals (Inst); Millennium (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Novartis